Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 327,454 |
| Cost of Goods | N/A | N/A | N/A | N/A | 43,525 |
| Gross Profit | N/A | N/A | N/A | N/A | 283,929 |
| Operating Expenses | 0 | 0 | 0 | 0 | 87,533 |
| Operating Income | N/A | N/A | N/A | N/A | 196,921 |
| Interest Expense | 0 | 0 | 0 | 0 | 328 |
| Other Income | 0 | 0 | 0 | 0 | 1,773 |
| Pre-tax Income | 0 | 0 | 0 | 0 | 198,366 |
| Income Tax | N/A | N/A | N/A | N/A | 25,665 |
| Net Income Continuous | N/A | N/A | N/A | N/A | 172,701 |
| Minority Interests | N/A | N/A | N/A | N/A | 63,871 |
| Net Income | $N/A | $N/A | $N/A | $N/A | $108,830 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | 1.08 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | 1.75 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | 0.99 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | 1.53 |
| EPS Diluted Before Non-Recurring Items | 1.02 | 0.10 | N/A | N/A | N/A |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $198,117 |